Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1143920190230020109
Annals of Hepato-Biliary-Pancreatic Surgery
2019 Volume.23 No. 2 p.109 ~ p.114
Molecular classification of hepatocellular adenoma: A single-center experience
Shen Xue-Yin

Hu Xu-Guang
Kim Young-Bae
Kim Mi-Na
Hong Sung-Yeon
Kim Bong-Wan
Wang Hee-Jung
Abstract
Backgrounds/Aims: Hepatocellular adenoma (HCA) is a rare benign tumor that has a risk of malignant transformation into hepatocellular carcinoma (HCC) and bleeding. The aim of this study was to analyze the characteristics of HCA by performing molecular classification.

Methods: We retrospectively collected data from nine patients who were diagnosed with HCA from 1995 to 2016. The patients underwent liver surgery due to the existence of clinical symptoms. Immunohistochemical (IHC) staining was performed to classify the subgroups of HCA.

Results: Four patients with both ¥â-catenin and inflammation were classified as ¥â-IHCA. Two patients were defined as ¥â-HCA. Two patients were classified as HHCA. Only one patient was defined as IHCA. None of the patients had unclassified HCA. Seven of nine patients had a malignant transformation. By comparing the characteristics of HCA between two groups, we found the mean tumor size in the malignant transformation group was greater than the non-malignant transformation group.

Conclusions: Taken together, the mean tumor size and activation of catenin ¥â1 mutation status might be the risk factors for the malignant transformation of HCA into HCC. Moreover, IHCA without the catenin ¥â1 mutation could also have a possibility of malignant transformation into HCC.
KEYWORD
Adenoma, Liver Cell, Molecular pathology, Subtype, Carcinoma, Hepatocellular
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed